Predisposing factors and prognosis of status epilepticus in patients with autoimmune encephalitis

被引:12
|
作者
Zhang, Yu [1 ,2 ]
Deng, Chen [1 ]
Zhu, Lina [1 ]
Ling, Liu [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Neurol, Wai Nan Guo Xue Lane 37, Chengdu 610041, Sichuan, Peoples R China
[2] Chengdu Shangjin Nanfu Hosp, Dept Neurol, Chengdu, Sichuan, Peoples R China
关键词
autoimmune encephalitis; prognosis; status epilepticus; GLUTAMIC-ACID DECARBOXYLASE; DIAGNOSIS; ANTIBODIES;
D O I
10.1097/MD.0000000000019601
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to study the predisposing factors and prognosis of status epilepticus (SE) in patients with autoimmune encephalitis (AE). A total of 227 cases of AE were collected from the inpatient department of West China Hospital of Sichuan University from January 2010 to May 2018. All patients met the 2015 criteria for the diagnosis of AE. The binary logistic regression model was used to multivariate and retrospective chart analysis the predisposition factors for SE and its prognostic factors. Of the 227 patients with AE, 50 (22.03%) had SE during hospitalization, and 19 patients with SE had a poor prognosis (modified Rankin score MRS = 3-6), and 7 patients with no SE had a poor prognosis. In the logistic regression model, electroencephalograms (EEGs) abnormalities (P = .000) and head magnetic resonance imaging (MRI) abnormalities (P = .003) were associated with a predisposition to SE, while Glasgow scores <8 (P = .027), abnormal EEG (P = .046), delayed immunotherapy (P = .012), and SE duration at admission lasting >30 minutes (P = .023) were risk factors for a poor prognosis of SE. SE is a common complication in patients with AE. EEG and MRI abnormalities may be predisposing factors for SE. Glasgow scores <8 points, abnormal EEG, delayed immunotherapy, and SE duration lasting >30 minutes at admission are risk factors for a poor prognosis in patients with SE.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Prognosis after Status Epilepticus
    Yeung, Maximus
    Fung, Faraday
    Wong, Yuen Kwun
    Chang, Richard
    Mak, Windsor
    Hon, Sonny
    Cheung, Raymond
    Ho, Shu Leong
    Chan, Koon Ho
    Lau, Gary
    NEUROLOGY, 2013, 80
  • [42] The EEG and prognosis in status epilepticus
    Nei, M
    Lee, JM
    Shanker, VL
    Sperling, MR
    EPILEPSIA, 1999, 40 (02) : 157 - 163
  • [43] Prognosis of convulsive status epilepticus
    Outin, H
    Thomas, P
    PROGNOSIS OF EPILEPSIES, 2003, : 300 - 310
  • [44] Status epilepticus: Management and prognosis
    Trinka, E.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [45] Prognosis in nonconvulsive status epilepticus
    Kaplan, PW
    EPILEPTIC DISORDERS, 2000, 2 (04) : 185 - 193
  • [46] Markers in Status Epilepticus Prognosis
    Alkhachroum, Ayham
    Der-Nigoghossian, Caroline A.
    Rubinos, Clio
    Claassen, Jan
    JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 2020, 37 (05) : 422 - 428
  • [47] Drug-Resistant Status Epilepticus Associated with GAD-65 Autoimmune Limbic Encephalitis
    Shafqat, Rafia
    Goswami, Vaibhav
    Moseley, Sydney
    Marks, Stephen
    NEUROLOGY, 2019, 92 (15)
  • [48] Refractory status epilepticus and autoimmune encephalitis with GABAAR and GAD65 antibodies: A case report
    Gagnon, Maude-Marie
    Savard, Martin
    Amari, Karim Mourabit
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2016, 37 : 25 - 27
  • [49] Myoclonic status epilepticus as a presentation of caspr2 antibody-associated autoimmune encephalitis
    Ramanathan, Sudarshini
    Wong, Chong H.
    Rahman, Zebunnessa
    Dale, Russell C.
    Fulcher, David
    Bleasel, Andrew F.
    EPILEPTIC DISORDERS, 2014, 16 (04) : 477 - 481
  • [50] RISK FACTORS FOR STATUS EPILEPTICUS IN PAEDIATRIC PATIENTS
    Ahmed, M. A.
    Pitts, J. R.
    Aldahash, Z.
    Haque, A.
    EPILEPSIA, 2015, 56 : 105 - 105